AC
Asio Capital Portfolio holdings
AUM
$781M
Turnover
15.97%
1-Year Est. Return
26.78%
This Fund
S&P 500
This Quarter
Est. Return
+1.93%
1 Year Est. Return
+26.78%
3 Year Est. Return
+88.02%
5 Year Est. Return
+109.54%
10 Year Est. Return
–
AUM
$529M
AUM Growth
+$2.6M
(+0.49%)
Cap. Flow
-$329K
Cap. Flow
% of AUM
-0.06%
Top 10 Holdings %
Top 10 Hldgs %
38.34%
Holding
111
New
5
Increased
34
Reduced
56
Closed
7
Avg Time Held
2.7
years
Top 10 Avg Time Held
2.2
years
Top 20 Avg Time Held
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Intermediately-Term US Treasury ETF
SCHR
|
+$4.43M |
| 2 |
Eli Lilly
LLY
|
+$3.39M |
| 3 |
T. Rowe Price Small-Mid Cap ETF
TMSL
|
+$2.89M |
| 4 |
JPMorgan Municipal ETF
JMUB
|
+$2.78M |
| 5 |
BlackRock Flexible Income ETF
BINC
|
+$2.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$5.45M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$5.18M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$2.39M |
| 4 |
Medtronic
MDT
|
+$2.28M |
| 5 |
Ulta Beauty
ULTA
|
+$2.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.96% |
| 2 | Technology | 21.8% |
| 3 | Consumer Discretionary | 9.89% |
| 4 | Financials | 8.54% |
| 5 | Healthcare | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Linde
LIN
$227B
| $224K | 0.04% |
535
-25
| -4% | -$11.4K |
2023 Q2
6 quarters
|
|
102
Oracle
ORCL
$394B
| $220K | 0.04% |
1,320
| – | – |
2024 Q3
1 quarter
|
|
103
Mondelez International
MDLZ
$80.1B
| $217K | 0.04% |
3,641
| – | – |
2022 Q1
11 quarters
|
|
104
Steris
STE
$21.2B
| $202K | 0.04% |
983
-15
| -2% | -$3.29K |
2023 Q4
4 quarters
|
|
105
iShares Select Dividend ETF
DVY
$22.8B
| – | – |
-1,500
| Closed | -$203K | – |
|
106
Schwab Fundamental International Large Company Index ETF
FNDF
$25.3B
| – | – |
-5,815
| Closed | -$217K | – |
|
107
Goldman Sachs Equal Weight US Large Cap Equity ETF
GSEW
$2.16B
| – | – |
-8,962
| Closed | -$694K | – |
|
|
108
Medtronic
MDT
$119B
| – | – |
-25,287
| Closed | -$2.28M | – |
|
109
Parker-Hannifin
PH
$120B
| – | – |
-339
| Closed | -$214K | – |
|
110
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.4B
| – | – |
-3,903
| Closed | -$206K | – |
|
|
111
Vertex Pharmaceuticals
VRTX
$126B
| – | – |
-11,128
| Closed | -$5.18M | – |
|
Similar funds
HI
QCM
SAM
LTI
NGM
PCM
WC
SFWA
Asio Capital's Q4 2024 Portfolio in Review
As of Q4 2024, Asio Capital held 111 positions worth $529M, up 0.49% from $527M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Asio Capital's Q4 2024 filing shows 5 new, 34 increased, 56 reduced and 7 closed positions. Its largest new stake was Schwab Intermediately-Term US Treasury ETF: 180,014 shares worth $4.37M. The largest sale was iShares 5-10 Year Investment Grade Corporate Bond ETF, an estimated $5.45M.
By sector, the portfolio is most concentrated in Miscellaneous at 31% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
- Asio Capital's largest Q4 2024 buy was Schwab Intermediately-Term US Treasury ETF: 180,014 shares worth $4.37M.
- Asio Capital added most to Eli Lilly in Q4 2024, an estimated $3.39M increase.
- Asio Capital's biggest Q4 2024 reduction was iShares 5-10 Year Investment Grade Corporate Bond ETF, cutting an estimated $5.45M.
- Asio Capital fully exited Vertex Pharmaceuticals in Q4 2024, selling an estimated $5.18M.
- Asio Capital's ten largest holdings make up 38% of its $529M portfolio in Q4 2024.
- Asio Capital opened 5 new positions and closed 7 in Q4 2024.
- Asio Capital's portfolio value rose 0.49% quarter-over-quarter to $529M.
Based on Asio Capital's 13F filing for Q4 2024, filed 21 Jan 2025.